News Revvity, Inc.

Equities

RVTY

US7140461093

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
111.9 ^USD	-1.24%		-1.21%	+2.33%

May. 14	Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Apr. 30	TD Cowen Adjusts Price Target on Revvity to $130 From $123	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Revvity to Present at Goldman Sachs Global Healthcare Conference	May. 28	BU
Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	May. 14
Revvity : Q1 2024 Earnings Transcript	Apr. 30	PU
TD Cowen Adjusts Price Target on Revvity to $130 From $123	Apr. 30	MT
JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	Apr. 30	MT
Baird Adjusts Price Target on Revvity to $127 From $126	Apr. 30	MT
Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating	Apr. 30	MT
Nephron Adjusts Revvity's Price Target to $124 From $120	Apr. 29	MT
Transcript : Revvity, Inc., Q1 2024 Earnings Call, Apr 29, 2024	Apr. 29
Revvity beats quarterly estimates on demand for diagnostic equipment	Apr. 29	RE
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	Apr. 29	MT
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M	Apr. 29	MT
Revvity: Q1 Earnings Snapshot	Apr. 29	AQ
Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94	Apr. 29	MT
Revvity Announces Financial Results for the First Quarter of 2024	Apr. 29	BU
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	Apr. 29	CI
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Revvity Board Declares Quarterly Dividend	Apr. 25	BU
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	Apr. 25	CI
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings	Apr. 25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Revvity, Inc.

Equities

RVTY

US7140461093

Summary

Filters